281 related articles for article (PubMed ID: 21840883)
1. Detrimental effect of fractalkine on myocardial ischaemia and heart failure.
Xuan W; Liao Y; Chen B; Huang Q; Xu D; Liu Y; Bin J; Kitakaze M
Cardiovasc Res; 2011 Dec; 92(3):385-93. PubMed ID: 21840883
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol improves myocardial ischemia and ischemic heart failure in mice by antagonizing the detrimental effects of fractalkine*.
Xuan W; Wu B; Chen C; Chen B; Zhang W; Xu D; Bin J; Liao Y
Crit Care Med; 2012 Nov; 40(11):3026-33. PubMed ID: 22926332
[TBL] [Abstract][Full Text] [Related]
3. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
4. Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling.
Dahl CP; Husberg C; Gullestad L; Waehre A; Damås JK; Vinge LE; Finsen AV; Ueland T; Florholmen G; Aakhus S; Halvorsen B; Aukrust P; Oie E; Yndestad A; Christensen G
Circ Heart Fail; 2009 Nov; 2(6):624-32. PubMed ID: 19919988
[TBL] [Abstract][Full Text] [Related]
5. Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure.
Husberg C; Nygård S; Finsen AV; Damås JK; Frigessi A; Oie E; Waehre A; Gullestad L; Aukrust P; Yndestad A; Christensen G
J Mol Cell Cardiol; 2008 Aug; 45(2):261-9. PubMed ID: 18585734
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.
Westenbrink BD; Ruifrok WP; Voors AA; Tilton RG; van Veldhuisen DJ; Schoemaker RG; van Gilst WH; de Boer RA
Cardiovasc Res; 2010 Jul; 87(1):30-9. PubMed ID: 20139114
[TBL] [Abstract][Full Text] [Related]
7. Elevated levels of activin A in heart failure: potential role in myocardial remodeling.
Yndestad A; Ueland T; Øie E; Florholmen G; Halvorsen B; Attramadal H; Simonsen S; Frøland SS; Gullestad L; Christensen G; Damås JK; Aukrust P
Circulation; 2004 Mar; 109(11):1379-85. PubMed ID: 14993131
[TBL] [Abstract][Full Text] [Related]
8. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
9. Decreased myocardial chromogranin a expression and colocalization with brain natriuretic peptide during reverse cardiac remodeling after ventricular unloading.
Wohlschlaeger J; von Winterfeld M; Milting H; El Banayosy A; Schmitz KJ; Takeda A; Takeda N; Azhari P; Schmid C; August C; Schmid KW; Baba HA
J Heart Lung Transplant; 2008 Apr; 27(4):442-9. PubMed ID: 18374882
[TBL] [Abstract][Full Text] [Related]
10. HMGB1: the missing link between diabetes mellitus and heart failure.
Volz HC; Seidel C; Laohachewin D; Kaya Z; Müller OJ; Pleger ST; Lasitschka F; Bianchi ME; Remppis A; Bierhaus A; Katus HA; Andrassy M
Basic Res Cardiol; 2010 Nov; 105(6):805-20. PubMed ID: 20703492
[TBL] [Abstract][Full Text] [Related]
11. Benidipine, a long-acting calcium channel blocker, inhibits cardiac remodeling in pressure-overloaded mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Asanuma H; Minamino T; Tomoike H; Hori M; Kitakaze M
Cardiovasc Res; 2005 Mar; 65(4):879-88. PubMed ID: 15721868
[TBL] [Abstract][Full Text] [Related]
12. Fractalkine neutralization improves cardiac function after myocardial infarction.
Gu X; Xu J; Yang XP; Peterson E; Harding P
Exp Physiol; 2015 Jul; 100(7):805-17. PubMed ID: 25943588
[TBL] [Abstract][Full Text] [Related]
13. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
[TBL] [Abstract][Full Text] [Related]
14. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
You JJ; Yang CH; Huang JS; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
[TBL] [Abstract][Full Text] [Related]
15. Syndecan-4 signalling inhibits apoptosis and controls NFAT activity during myocardial damage and remodelling.
Echtermeyer F; Harendza T; Hubrich S; Lorenz A; Herzog C; Mueller M; Schmitz M; Grund A; Larmann J; Stypmann J; Schieffer B; Lichtinghagen R; Hilfiker-Kleiner D; Wollert KC; Heineke J; Theilmeier G
Cardiovasc Res; 2011 Oct; 92(1):123-31. PubMed ID: 21632883
[TBL] [Abstract][Full Text] [Related]
16. Fractalkine expression and CD16+ monocyte accumulation in glomerular lesions: association with their severity and diversity in lupus models.
Nakatani K; Yoshimoto S; Iwano M; Asai O; Samejima K; Sakan H; Terada M; Hasegawa H; Nose M; Saito Y
Am J Physiol Renal Physiol; 2010 Jul; 299(1):F207-16. PubMed ID: 20410215
[TBL] [Abstract][Full Text] [Related]
17. CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in mice.
Montecucco F; Braunersreuther V; Lenglet S; Delattre BM; Pelli G; Buatois V; Guilhot F; Galan K; Vuilleumier N; Ferlin W; Fischer N; Vallée JP; Kosco-Vilbois M; Mach F
Eur Heart J; 2012 Aug; 33(15):1964-74. PubMed ID: 21606075
[TBL] [Abstract][Full Text] [Related]
18. Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan-4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure-overloaded heart.
Strand ME; Herum KM; Rana ZA; Skrbic B; Askevold ET; Dahl CP; Vistnes M; Hasic A; Kvaløy H; Sjaastad I; Carlson CR; Tønnessen T; Gullestad L; Christensen G; Lunde IG
FEBS J; 2013 May; 280(10):2228-47. PubMed ID: 23374111
[TBL] [Abstract][Full Text] [Related]
19. Loss of NOX2 (gp91phox) prevents oxidative stress and progression to advanced heart failure.
Parajuli N; Patel VB; Wang W; Basu R; Oudit GY
Clin Sci (Lond); 2014 Sep; 127(5):331-40. PubMed ID: 24624929
[TBL] [Abstract][Full Text] [Related]
20. Cardiomyocyte-restricted over-expression of C-type natriuretic peptide prevents cardiac hypertrophy induced by myocardial infarction in mice.
Wang Y; de Waard MC; Sterner-Kock A; Stepan H; Schultheiss HP; Duncker DJ; Walther T
Eur J Heart Fail; 2007; 9(6-7):548-57. PubMed ID: 17407830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
